Verastem, Inc. (VSTM) income statement
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.87−0.54 (-7.29%)
Close on Nov 18, 2026Market cap $622.17MP/E –Yield –
Verastem, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -182.6%
- Net margin
- -231.6%
- Return on equity, FY2025
- -1480.2%
Financial strength
- Current ratio
- 2.25
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 174.5%
Valuation
- P/E ratio
- –
- Price to sales
- 7.11
- Price to book
- 12.45
- Dividend yield
- –
See a number that looks wrong?